뇌심부 자극 기기 시장 규모, 점유율, 동향 분석 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Deep Brain Stimulation Devices Market Summary

The global deep brain stimulation devices market size was estimated at USD 1.54 billion in 2025 and is projected to reach USD 3.47 billion by 2033, growing at a CAGR of 10.88% from 2026 to 2033. The major factors driving the market growth are rising prevalence of neurological disorders such as Parkinson's disease and epilepsy, introduction of technologically advanced products, escalating product demand as add-on therapy, and the growing demand for minimally invasive procedures.

The increasing prevalence of neurological disorders is a major driver of the deep brain stimulation devices market. Conditions such as Parkinson's disease, epilepsy, depression, dystonia, and essential tremor are rising globally, creating a larger patient population requiring advanced treatment options.

Global Deep Brain Stimulation Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global deep brain stimulation devices market report on the basis of product, application, end-use and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Single Channel
• Dual Channel
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Pain Management
• Epilepsy
• Essential Tremor
• Obsessive-compulsive Disorders (OCD)
• Depression
• Dystonia
• Parkinson's Disease
• Others
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Neurology Clinics
• Ambulatory Surgical Centers
• Research Centers
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Product
  • 1.1.2. Application
  • 1.1.3. End Use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
  • 1.5.1. Data for primary interviews in North America
  • 1.5.2. Data for primary interviews in Europe
  • 1.5.3. Data for primary interviews in Asia Pacific
  • 1.5.4. Data for primary interviews in Latin America
  • 1.5.5. Data for Primary interviews in MEA
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Deep Brain Stimulation Devices Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing incidences of neurological disorders
    • 3.2.1.2. Technological advancements in DBS devices
    • 3.2.1.3. Increasing preference for targeted therapy approach
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Complex regulatory framework
    • 3.2.2.2. Complications and risks associated with DBS procedures
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Expansion of therapeutic indications
    • 3.2.3.2. Growth in emerging healthcare markets
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Limited patient awareness and diagnosis
• 3.3. Deep Brain Stimulation Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Deep Brain Stimulation Devices Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Deep Brain Stimulation Devices Market Movement Analysis
• 4.3. Global Deep Brain Stimulation Devices Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.3.1. Single Channel
    • 4.3.1.1. Single Channel Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit)
  • 4.3.2. Dual Channel
    • 4.3.2.1. Dual Channel Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit)

Chapter 5. Deep Brain Stimulation Devices Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Deep Brain Stimulation Devices Market Movement Analysis
• 5.3. Global Deep Brain Stimulation Devices Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million, Volume Unit)
• 5.4. Pain Management
  • 5.4.1. Pain Management Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit)
• 5.5. Epilepsy
  • 5.5.1. Epilepsy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit)
• 5.6. Essential Tremor
  • 5.6.1. Essential Tremor Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit)
• 5.7. Obsessive-compulsive Disorders (OCD)
  • 5.7.1. Obsessive-compulsive Disorders (OCD) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit)
• 5.8. Depression
  • 5.8.1. Depression Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit)
• 5.9. Dystonia
  • 5.9.1. Dystonia Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit)
• 5.10. Others
  • 5.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit)

Chapter 6. Deep Brain Stimulation Devices Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Deep Brain Stimulation Devices Market Movement Analysis
• 6.3. Global Deep Brain Stimulation Devices Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million, Volume Unit)
• 6.4. Hospitals
  • 6.4.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit)
• 6.5. Neurology Clinics
  • 6.5.1. Neurology Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit)
• 6.6. Ambulatory Surgical Centers
  • 6.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit)
• 6.7. Research Centers
  • 6.7.1. Research Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million, Volume Unit)

Chapter 7. Deep Brain Stimulation Devices Market: Regional Estimates & Trend Analysis By Product, By Application, By End Use

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 7.3. North America
  • 7.3.1. North America Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Scenario
    • 7.3.2.4. Reimbursement Scenario
    • 7.3.2.5. U.S. Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Scenario
    • 7.3.3.4. Reimbursement Scenario
    • 7.3.3.5. Canada Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Regulatory Scenario
    • 7.3.4.4. Reimbursement Scenario
    • 7.3.4.5. Mexico Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Scenario
    • 7.4.2.4. Reimbursement Scenario
    • 7.4.2.5. UK Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Scenario
    • 7.4.3.4. Reimbursement Scenario
    • 7.4.3.5. Germany Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Scenario
    • 7.4.4.4. Reimbursement Scenario
    • 7.4.4.5. France Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Scenario
    • 7.4.5.4. Reimbursement Scenario
    • 7.4.5.5. Italy Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Regulatory Scenario
    • 7.4.6.4. Reimbursement Scenario
    • 7.4.6.5. Spain Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Scenario
    • 7.4.7.4. Reimbursement Scenario
    • 7.4.7.5. Sweden Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Competitive Scenario
    • 7.4.8.3. Regulatory Scenario
    • 7.4.8.4. Reimbursement Scenario
    • 7.4.8.5. Denmark Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key Country Dynamics
    • 7.4.9.2. Competitive Scenario
    • 7.4.9.3. Regulatory Scenario
    • 7.4.9.4. Reimbursement Scenario
    • 7.4.9.5. Norway Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Scenario
    • 7.5.2.4. Reimbursement Scenario
    • 7.5.2.5. Japan Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Scenario
    • 7.5.3.4. Reimbursement Scenario
    • 7.5.3.5. China Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Scenario
    • 7.5.4.4. Reimbursement Scenario
    • 7.5.4.5. India Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Scenario
    • 7.5.5.4. Reimbursement Scenario
    • 7.5.5.5. South Korea Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Scenario
    • 7.5.6.4. Reimbursement Scenario
    • 7.5.6.5. Australia Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Scenario
    • 7.5.7.4. Reimbursement Scenario
    • 7.5.7.5. Thailand Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Scenario
    • 7.6.2.4. Reimbursement Scenario
    • 7.6.2.5. Brazil Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Scenario
    • 7.6.3.4. Reimbursement Scenario
    • 7.6.3.5. Argentina Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Middle East & Africa
  • 7.7.1. Middle East & Africa Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Scenario
    • 7.7.2.4. Reimbursement Scenario
    • 7.7.2.5. South Africa Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Scenario
    • 7.7.3.4. Reimbursement Scenario
    • 7.7.3.5. Saudi Arabia Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Scenario
    • 7.7.4.4. Reimbursement Scenario
    • 7.7.4.5. UAE Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Scenario
    • 7.7.5.4. Reimbursement Scenario
    • 7.7.5.5. Kuwait Deep Brain Stimulation Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis by Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Market Share Analysis, 2025
• 8.4. Company Heat Map Analysis
• 8.5. Strategy Mapping
  • 8.5.1. Expansion
  • 8.5.2. Mergers & Acquisition
  • 8.5.3. Partnerships & Collaborations
  • 8.5.4. New Product Launches
  • 8.5.5. Research And Development
  • 8.5.6. Company Profiles
  • 8.5.7. Medtronic
    • 8.5.7.1. Company overview
    • 8.5.7.2. Financial performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic initiatives
  • 8.5.8. Boston Scientific Corporation
    • 8.5.8.1. Company overview
    • 8.5.8.2. Financial performance
    • 8.5.8.3. Product Benchmarking
    • 8.5.8.4. Strategic initiatives
  • 8.5.9. Abbott
    • 8.5.9.1. Company overview
    • 8.5.9.2. Financial performance
    • 8.5.9.3. Product Benchmarking
    • 8.5.9.4. Strategic initiatives
  • 8.5.10. Aleva Neurotherapeutics
    • 8.5.10.1. Company overview
    • 8.5.10.2. Financial performance
    • 8.5.10.3. Product Benchmarking
    • 8.5.10.4. Strategic initiatives
  • 8.5.11. Newronika S.p.A.
    • 8.5.11.1. Company overview
    • 8.5.11.2. Financial performance
    • 8.5.11.3. Product Benchmarking
    • 8.5.11.4. Strategic initiatives
  • 8.5.12. Beijing PINS Medical Co., Ltd.
    • 8.5.12.1. Company overview
    • 8.5.12.2. Financial performance
    • 8.5.12.3. Product Benchmarking
    • 8.5.12.4. Strategic initiatives
  • 8.5.13. Neuronetics (Neurostar)
    • 8.5.13.1. Company overview
    • 8.5.13.2. Financial performance
    • 8.5.13.3. Product Benchmarking
    • 8.5.13.4. Strategic initiatives